Virtu Financial LLC Ac Immune Sa Transaction History

Virtu Financial LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 26, 2024	BUY	$2.46 - $5.0 $28,417 - $57,760	11,552 New	11,552 $58,000
Q4 2022 Feb 15, 2023	BUY	$1.72 - $3.12 $61,061 - $110,763	35,501 New	35,501 $72,000
Q4 2020 Feb 24, 2021	SELL	$4.47 - $5.58 $146,048 - $182,315	-32,673 Closed	0 $0
Q3 2020 Dec 11, 2020	BUY	$4.78 - $9.06 $156,176 - $296,017	32,673 New	32,673 $159,000
Q2 2019 Aug 13, 2019	SELL	$4.72 - $5.88 $370,845 - $461,985	-78,569 Closed	0 $0
Q1 2019 Apr 12, 2019	BUY	$3.65 - $11.68 $249,528 - $798,491	68,364 Added 669.91%	78,569 $397,000
Q1 2018 May 14, 2018	BUY	$10.34 - $13.78 $105,519 - $140,624	10,205 New	10,205 $106,000

28.2M

150K

12.4K

Ticker ACIU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,413,504
Market Cap $296M
Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.